Fig. 7: Expression of sialylated glycosphingolipids in Parkinson’s disease. | Nature Communications

Fig. 7: Expression of sialylated glycosphingolipids in Parkinson’s disease.

From: Extended coverage of human serum glycosphingolipidome by 4D-RP-LC TIMS-PASEF unravels association with Parkinson’s disease

Fig. 7

a Heatmap showing the upregulated (top) and down-regulated (bottom) differentially expressed sialylated GSLs after FDR correction. For visualization purpose, raw expression values were organized according to group (control and Parkinson’s Disease) and sex (female and male); b Biosynthetic pathway of ganglio- and neolacto-series (www.genome.jp and www.lipidmaps.org) of glycosphingolipids (GSLs) with highlighted upregulated subclasses. Source data are provided as a Source Data file.

Back to article page